| Financial Year |
March 31 2023 |
| Monetary Funds |
5,920,315.43 |
| Held-for-trading Financial Assets |
126,571,653.50 |
| Notes Receivable |
-- |
| Accounts Receivable |
22,768,230.27 |
| Advances to Suppliers |
3,342,109.00 |
| Other Receivables |
11,672,666.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
70,769,123.90 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
7,493.35 |
| Total Current Assets |
241,151,591.67 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
8,681,697.71 |
| Fixed Assetes |
457,540,234.74 |
| Under-construction Projects |
3,659,307.42 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
65,903,507.16 |
| R&D expenses |
96,743,142.32 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
3,985,817.50 |
| Deferred Income Tax Assets |
970,228.42 |
| Other Non-Current Assets |
12,148,917.38 |
| Sub-Total of Non-Current Assets |
649,632,852.65 |
| Total Assets |
890,784,444.32 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
15,437,617.37 |
| Accounts Received In Advance |
824,274.65 |
| Employee Compensation Payable |
5,860,557.02 |
| Taxes Payable |
3,265,795.21 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
55,239,285.40 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
201,475,380.01 |
| Other Current Liabilities |
777,014.84 |
| Sub-Total of Current Liabilities |
298,540,425.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,078,500.21 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
10,487,190.48 |
| Total Liabilities |
309,027,615.64 |
| Paid-In Capital(Or Share Stock) |
414,737,000.00 |
| Capital Surplus |
369,692,405.49 |
| Surplus Reserve |
34,425,232.98 |
| LESS:Treasury Stock |
8,022,000.00 |
| Undistributed Profits |
-291,712,083.92 |
| Minority Stockholder's Interest |
62,992,333.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
518,764,494.90 |
| Owner's Equity（Stockholder's Equity） |
581,756,828.68 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
890,784,444.32 |
